Motivation: High through-put mass spectrometry (MS) is now being used to profile small molecular compounds across multiple biological sample types from the same subjects with the goal of leveraging information across biospecimens. Multivariate statistical methods that combine information from all biospecimens could be more powerful than the usual univariate analyses. However, missing values are common in MS data and imputation can impact betweenbiospecimen correlation and multivariate analysis results. Results: We propose two multivariate two-part statistics that accommodate missing values and combine data from all biospecimens to identify differentially regulated compounds. Statistical significance is determined using a multivariate permutation null distribution. Relative to univariate tests, the multivariate procedures detected more significant compounds in three biological datasets. In a simulation study, we showed that multi-biospecimen testing procedures were more powerful than single-biospecimen methods when compounds are differentially regulated in multiple biospecimens but univariate methods can be more powerful if compounds are differentially regulated in only one biospecimen. Availability and Implementation: We provide R functions to implement and illustrate our method as supplementary information.
Introduction
High through-put mass spectrometry (MS) is now widely used to analyze small molecular compounds such as metabolites, lipids, proteins and glycans in biological samples. By being able to profile 100s to 1000s of compounds simultaneously, MS can advance identification of compounds for therapeutic targets and clinical tests, both diagnostic and prognostic, as well as discern biological pathways.
A natural progression in the application of MS technology is to collect and analyze multiple sample types (herein referred to as 'biospecimens') from the same subjects (e.g. serum, plasma, tissue and urine) (Chen et al., 2012; Jordan et al., 2010; Yonezawa et al., 2013) . Combining information from multiple biospecimens could enhance identification of interesting compounds and improve understanding of physiological process.
When omics data are obtained for multiple biospecimens from the same subject, analyses typically are conducted for each biospecimen separately and then results qualitatively compared across the biospecimens (Austdal et al., 2014; Ganti et al., 2012; Witowski et al., 2015; Yonezawa et al., 2013) . However, multiple samples from the same subject are correlated and individually analyzing each biospecimen does not take advantage of this correlation. Multivariate analysis methods that integrate information from all biospecimens can be more powerful than univariate analyses (Taylor et al., 2016) .
MS studies commonly have a large amount of missing data (see e.g. Hrydziuszko and Viant, 2011; Wang et al., 2012; WebbRobertson et al., 2015) which presents a significant challenge for statistical analysis (see e.g. Clough et al., 2009) . Analysis of such datasets can follow one of two approaches of either eliminating missing values prior to analysis or using methods that integrate missing values in the testing procedure. Strategies for eliminating missing values include removing individual compounds or samples with missing values and/or imputing the missing values. A common approach is to eliminate individual compounds with missing values greater than a pre-selected exclusion threshold, and then to impute any remaining missing values. This manipulation yields a complete dataset to which standard statistical methods can be applied. Several imputation techniques have been shown to perform adequately for single biospecimen analyses for up to about 20% missing data (Gromski et al., 2014; Hrydziuszko and Viant, 2011) . However, for multiple biospecimen investigations, we recently showed that a wide range of imputation methods result in substantial changes to the betweenbiospecimen correlation and multivariate analysis of variance (MANOVA) inferential results, particularly when large amounts of missing data are present (Taylor et al., 2016) .
The second approach entails using statistical methods that allow for missing values. Several statistical methods accommodate missing data and have been applied to MS data including accelerated failure time models (Tekwe et al., 2012) , two-part models (Taylor and Pollard, 2009 ) and mixture models (Karpievitch et al., 2009; Taylor et al., 2013) . The assumptions about the missing value mechanisms differ among these methods and as a consequence, missing values are modeled in different manners. Accelerated failure time models come from survival analysis (Klein and Moeschberger, 2003) and assume that missing values represent compounds that are present in the sample but censored at concentrations below the detection limit. In two-part models, all missing values are modeled as a 'point-mass', typically at zero, and a compound's distribution is characterized by the proportion of observations in the point-mass representing the proportion of missing values and the distribution of the observed values (Taylor and Pollard, 2009 ). These models jointly test for a difference in the proportion of missing values and a difference in the means of the continuous components (Lachenbruch, 2001 ). Mixture models combine elements from survival analysis and two-part models by modeling missing values as a combination of censored values and the absence of a compound represented as a point-mass at 0 (Karpievitch et al., 2009; Taylor et al., 2013) . These methods have only been used for single biospecimen analyses and few methods suitable for multivariate analysis of data with missing values have been developed. Farcomeni (2016) developed a two-part MANOVA test for multivariate lognormal data with a spike at zero. This procedure was applied to ecological data and while it could be applicable to omics data which are often assumed to be log-normally distributed, it has not been evaluated in this context. Multivariate extensions of Gehan and logrank tests for survival analysis have been developed (Wei and Lachin, 1984) and Thulin (2016) adapted these to left-censored data in a recent study evaluating several multivariate analysis procedures for data with detection limit censoring.
We present a multivariate analytical approach that leverages signals from compounds in all biospecimens. Our method allows for and actually exploits missing values as part of each compound's 'signal'. By integrating missing values into our testing procedure, we can rely on the true properties of the data at hand for analysis without imputation. We show that our method yields higher power for detecting differentially regulated compounds than single biospecimen methods while controlling the Type I error rate.
Methods

Test statistics and significance determination
In analyzing MS data to identify compounds differentially regulated in response to an experimental factor the usual approach is to test for differences in mean intensities between experimental groups. However, when missing values are present, a compound's observed distribution consists of two components, the proportion of missing observations and the distribution of the observed, continuous values. Missing values in mass spectrometry arise for multiple reasons including randomly due to technical issues but also due to the occurrence of compounds at concentrations below a pre-determined threshold or by truncation based on a signal-to-noise ratio. Webb-Robertson et al. (2015) and Hrydziuszko and Viant (2011) both showed that the proportion of missing values increases with declining peak abundance suggesting some detection limit censoring. For missing values arising from detection limit censoring, the unobserved values are small and would decrease the mean if they had been observed. When missing values result from censoring, both the distribution of observed values and the proportion of missing values are informative with respect to identifying differentially regulated compounds.
We propose to use two-part statistics to exploit information in both the continuous and binary components of MS data with missing values. We address the common inferential testing framework of identifying compounds that are significantly differentially regulated between two experimental groups. For a single biospecimen, a twopart statistic tests the following null hypothesis for each compound, g
against the alternative hypothesis
where l 1 and l 2 are the means of the non-missing observations for the cases and controls, respectively, p 1 and p 2 are the respective proportions of missing values and h and s are known constants, usually taken as 0. In our approach, we combine biospecimen-specific test statistics across two or more biospecimens to test the joint null hypothesis
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where m indexes the biospecimen. We construct our test statistic as follows. Consider a compound signify up-regulation in cases). If missing values arise randomly with respect to compound levels, all experimental groups will be equally impacted and (i) the proportion of missing values will not differ between groups, and (ii) the true means of the experimental groups will not be biased by missingness. In our test statistic, the expected value of the binomial component would be 0 indicating no difference in the proportion of missing values and the test statistic would be determined by the mean component. In this situation, the mean test component will remain unbiased for the true difference in means. Thus, while we do not explicitly assume and incorporate a particular missing value mechanism, our method encompasses different mechanisms.
The T g test statistic is sensitive to the direction of the differences within and between biospecimens. Within a biospecimen, consonant differences occur when the group with the higher mean has fewer missing values; this situation would be reflective of missing values representing small values. Dissonant differences occur when the group with the larger mean has more missing values. Given the way we construct the test statistics, consonant differences increase T g while dissonant differences decrease T g . Between biospecimens, we define consonant between-biospecimen mean and proportion differences as when the differences in means and proportions of the two groups are in same direction in each biospecimen, respectively while dissonant differences occur when the difference in means or proportions are in different directions in different biospecimens. It is important to recognize that T g increases with consonant biospecimen differences and decreases with dissonant biospecimen differences. As a result, for compounds that are differentially regulated in opposite directions between biospecimens (i.e. dissonant difference), T g can be nonsignificant even if there are significant within biospecimen differences due to the single-biospecimen components cancelling each other. Alternatively we can construct a test statistic that is only sensitive to the magnitude of the differences in means and proportions of missing values and not the direction,
gm . To test whether compound g is differentially regulated, we again sum the individual biospecimen test statistics to obtain the multibiospecimen test statistic,
gm . This test statistic evaluates whether the means and proportions differ between experimental groups irrespective of whether the differences are consonant or dissonant within or between biospecimens.
For both multi-biospecimen statistics, the null distributions are unknown. Thus, we use a multivariate permutation procedure to obtain the null distribution of the multi-biospecimen test statistics and determine significance (Pesarin, 2001) . We permute class labels and recalculate the biospecimen-specific and multi-biospecimen test statistics. This approach preserves the within-subject correlation structure across the biospecimens for each compound and avoids the difficulty of defining a parametric null distribution. Further, it is suitable for small sample sizes for which asymptotic distributional assumptions might not be appropriate. R code to implement our method is provided in Supplementary Information.
Biological datasets
We evaluated our proposed method in three biological datasets: (i) Lung Cancer Serum/Plasma glycomics data (LC-SP), (ii) Lung Cancer Serum/Plasma/Dried Blood glycomics data (LC-DBS) and (iii) Renal Cell Carcinoma Xenograft metabolomics data (Xenograft). These datasets are provided as supplemental information. For comparison to our proposed multi-biospecimen statistics (T g and T 2 g ), we also evaluated differential regulation in each biospecimen independently using two-sample t-tests of observed values only, and both two-part statistics (T gm and T 2 gm ). A Bonferroni adjustment was applied to single biospecimen P-values to maintain the type I error rate at 0.05 across biospecimens for a compound. For all statistics, we used 5000 permutations for the null distribution to determine significance.
Renal cell carcinoma xenograft metabolomics
A metabolomics study of tissue, serum and urine was conducted of renal cell carcinoma using xenograft and sham surgery control mice. Human Caki-1 cells were xenografted into seven nude mice and seven mice were subjected to sham surgery. All mice were sacrificed 34 days after surgery when the xenografted animals became moribund. Terminal serum was collected, and tumor (from xenografted animals) and normal kidneys (from sham surgery animals) were removed for tissue analysis. Urine was collected 32 days after surgery (2 days before sacrifice). Non-targeted metabolomics was accomplished using three different platforms: ultra-high performance liquid chromatography/tandem mass spectrometry (UHLC/MS/ MS2) optimized for basic species, UHLC/MS/MS2 optimized for acidic species, and gas chromatography/mass spectrometry (GC/ MS). Equal masses of tissue samples were used in chromatographic analysis. Detailed information on the experimental procedures and metabolomic platforms were previously described in detail (Ganti et al., 2012) . To illustrate our method, we retained 100 compounds detected in at least one sample in each biospecimen for analysis. For the differential analysis, intensity values were log 2 transformed, centered at a mean of 0 and scaled to a variance of 1 to ensure all biological samples were similarly scaled.
Lung cancer serum and plasma glycomics
Blood samples (serum and plasma) were collected from 43 subjects diagnosed with non-small cell lung cancer (NSCLC) adenocarcinoma and 43 healthy controls recruited over a 4 year period (2010) (2011) (2012) (2013) (2014) from the UC Davis Medical Center and Cancer Center Clinics. Cancer patients were frequency matched with controls for gender, age and smoking history. Glycomics analysis was performed by enzymatic release of the N-glycans followed by purification and subsequent analysis using an Agilent nanoLC coupled to an Agilent time-of-flight (TOF) mass spectrometer equipped with a Chip-cube. Glycan separation was performed using a porous graphitized carbon stationary phase on a chip. Further information on sample processing, the mass spectrometric analysis and additional data processing approach is contained in (Kim et al., 2014; Ruhaak et al., 2013) .Within each biospecimen, the data were total quantity normalized and intensity values were then log 2 transformed. Intensity values were adjusted for age, gender and smoking history using linear regression and the residuals, scaled to a variance of 1, used in the differential analysis. In order to have a sufficient number of observations to adjust for covariates, we restricted the analysis to 253 glycans detected in at least 3 samples in each biospecimen and in each cancer group.
Lung cancer blood glycomics
Serum, plasma and dried blood spots were obtained from 10 subjects with NSCLC adenocarcinoma and 10 healthy controls matched for gender, age and smoking history. Glycomics analysis was performed using nLC-TOF-MS as described in the previous section. Collection, processing and analysis of serum and plasma samples is described in more detail in Kim et al. (2014) , Ruhaak et al. (2013) and in Ruhaak et al. (2012) for the dried blood samples. Within each biological biospecimen, the data were total quantity normalized and intensity values were then log 2 transformed. Intensity values were further adjusted for age, gender and smoking history using linear regression and the residuals, scaled to a variance of 1 used in the differential analysis. In order to have a sufficient number of observations to adjust for covariates, we restricted the analysis to 62 glycans detected in at least 3 samples in each biospecimen and in each cancer group.
Simulations
Simulations were conducted to assess the power and type I error of these procedures under a variety of known conditions including the degree of correlation between biospecimens, the number of biospecimens in which a compound is differentially regulated, and the magnitude and directions of the effect sizes. We simulated two possibly correlated variables such as would occur with samples of multiple biospecimens (e.g. plasma and serum) obtained from each patient. For all simulations we considered two groups, cases and controls, with 20 subjects in each group.
Data for the controls and cases were simulated from bivariate normal distributions. For the controls both variables had a mean of 0 and variance of 1. For the cases, data were simulated under two general settings-(i) differences in means between cases and controls in only one of the biospecimens (D 1 6 ¼ 0 and D 2 ¼ 0) and (ii) differences in means between cases and controls in both biospecimens (D 1 6 ¼ 0 and D 2 6 ¼ 0). We considered both consonant and dissonant mean differences (Table 1) . Consonant mean differences are when cases differ from controls in the same direction in both biospecimens, e.g. the compound shows higher abundance levels in the disease group in both plasma and serum as compared to the nondisease group. Dissonant mean differences are when cases differ from controls in opposite directions, e.g. a compound shows higher abundance in the disease group in tissue but lower abundance in blood. A range of correlations between the biospecimens was evaluated, specifically 60.75, 60.5, 60.25 and 0. The correlation indicates the direction and strength of the relationship of compound levels in two biospecimens from the same subject. For a compound with positive correlation between two biospecimens, subjects with high values in one biospecimen will tend to have high values in the other biospecimen, relative to the mean. Conversely, with negative correlation, compounds with high values in one biospecimen will tend to have low values in the other biospecimen relative to the mean. The correlation does not affect the direction or magnitude of the mean differences between cases and controls. To assess the type I error rate, we also simulated data under a null distribution of no difference in means in either biospecimen.
We first simulated data with no missing values in which case the B gm component of the two-part statistics was 0. Then, we simulated datasets with 10%, 25% and 50% missing values. We induced missingness through a restricted random sampling procedure similar to Scheel et al. (2005) . In this approach, values below a pre-determined threshold were randomly selected and set to missing. To generate 10% total missing, intensity values below the 25th quantile of each biospecimen were randomly selected and set to missing. To generate 25% missing, we sampled below the 50th quantile and for 50% we sampled from values below the 75th quantile. With this approach, lower values were more likely to be missing but a degree of randomness was retained thus mimicking the dynamics of biological datasets.
For each set of simulation parameters, we generated 10 000 datasets consisting of controls and cases and tested for differences between cases and controls using single biospecimen tests (two-sample Note that the means of the controls are set to zero. Consonant differences within biospecimens indicate that the experimental group with the higher mean of observed values has fewer missing values. Between biospecimens, percent consonant is the percentage of compounds for which the differences in means or proportions of missing values between experimental groups are in the same direction for two biospecimens.
t-tests and two-part statistics) and our proposed multi-biospecimen test statistics. An a-level of 0.05 was used to determine significance for the multi-biospecimen test statistics. For the single biospecimen tests, significance of a given compound was determined using an alevel of 0.025 in order to maintain the family-wise type I error rate at 0.05. We compared power of the procedures with power defined as the proportion of the simulated datasets for which each test was significant. Significance was determined using multivariate permutation null distributions consisting of 5000 permutations.
Results
Biological datasets
Data characteristics
The percentage of missing values for a given compound ranged from 0 to 90% across the three datasets thus covering a wide range of missing values (Supplemental Table S1 ). All combinations of correlations (positive and negative) between biospecimens, and mean and proportion differences (consonant and dissonant differences within and between biospecimens) occurred in these datasets (Supplemental Table S1 ). The majority of compounds were positively correlated between biospecimens, but, negative correlations occurred as well (Supplemental Table S1 ). Within each biospecimen, most compounds displayed consonant differences in terms of the means and proportions (Table 2 ). Between pairs of biospecimens, mean and proportion differences also were in the same direction for the majority of compounds. Figure 1 displays mean and proportion differences within and between serum and plasma for the LC-SP dataset to illustrate the possible patterns of differences.
Differential analysis results
For all datasets, the multi-biospecimen statistics always identified more significant compounds than found in any one biospecimen with the single-biospecimen statistics (Table 3) . For example, for LC_SP, the two multi-biospecimen statistics identified 30 significant compounds as compared to fewer than 20 in plasma or serum individually (Table 3 ). The multi-biospecimen methods also identified some compounds as significant that none of the single-biospecimen methods did. For LC_DBS, LC_SP and Xenograft datasets there were eight, nine and six such compounds (Fig. 2) . Conversely, a few compounds in each dataset were found to be differentially regulated in only one biospecimen by one or more of the single-biospecimen methods but were not significant based on either multi-biospecimen statistic (Fig. 2, Supplemental Table S2 ).
The two multi-biospecimen test statistics identified most of the same compounds as significant but for all datasets, there were some compounds identified as significant with one of the multibiospecimen test statistics but not the other (Fig. 2) . For LC_SP, eight compounds significant with T g were not significant with T 2 g and eight other compounds were significant with T 2 g but not T g (Fig.  2, Supplemental Table S2 ). Similarly for LC_DBS, four compounds were significant with T g and four with T 2 g that were not significant by the other multi-biospecimen test statistic; with the Xenograft data these numbers were 7 and 10. The compounds that were significant with T 2 g and not with T g had dissonant differences within and/or between biospecimens whereas those significant with only T g had consonant differences (Supplemental Table S2 ).
Simulation study results
Characteristics of simulated datasets
In our simulations, the group with the smaller mean usually had more missing values resulting in consonant differences in means and proportions within a biospecimen (Supplemental Tables S3-S5 ). In simulations with the group means differing in both biospecimens, between-biospecimen differences were mostly consonant when group differences were positive in both biospecimens but dissonant when effects were in different directions in the two biospecimens. For simulations with one null biospecimen, mean differences in the null biospecimen fluctuated around zero resulting in consonant between-biospecimen differences approximately 50% of the time.
Type I error rates
All test statistics controlled the type I error rate. The correlation between the two biospecimens did not substantially affect the error rates nor did the proportion of missing values (Supplemental Table S6 ).
Power when cases differ in both biospecimens
In our simulations of datasets with mean differences in both biological biospecimens, we considered both consonant and dissonant group differences between biospecimens. For data simulated with consonant between-biospecimen mean differences, both multibiospecimen test procedures had higher power than any of the single biospecimen statistics for all correlations at 10% and 25% missing values (Fig. 3, Supplemental Table S6 ). At 50% missing, T g continued to have higher power than any of the single biospecimen test statistics but power of T 2 g fell below that of the single biospecimen T gm statistic. Notably, both single-biospecimen two-part tests were more powerful than t-tests.
Comparing the two multi-biospecimen tests, T g always had higher power than T 2 g when between-biospecimen differences were consonant. The magnitude of the difference in power between these two statistics depended on the correlation which affected the power of T g more than T 2 g . The between-biospecimen correlation influences the power of T g by impacting its variance. When the biospecimens are negatively correlated, the variance of T g is reduced relative to the variance when the biospecimens are positively correlated or independent. However, the expectation of T g for a given difference in means and proportions remains the same regardless of the correlation. As a result of the smaller variance but equal expectation of T g , the null hypothesis is more likely to be rejected with T g for negatively correlated biospecimens than for positively correlated biospecimens (Fig. 4) .
When cases differed from controls in opposite directions in the two biospecimens (i.e. dissonant between-biospecimen differences), the dynamics changed. The power of T g was substantially reduced as the sum of the test statistics from the two biospecimens offset each other and yielded a small test statistic that resulted in this testing procedure having the lowest power of any procedure (Fig. 3 , Supplemental Table S6 ). The relative power of T g remained more powerful than all single biospecimen procedures at 10% missing and more powerful than t-tests and the single-biospecimen T 2 gm test at 25% and 50% missing but the single biospecimen T gm was more powerful at 25% missing in addition to 50% missing values.
Qualitatively, all procedures (both single and multi-biospecimen procedures) were similarly affected by the between-biospecimen correlation. When mean differences were consonant between biospecimens, all procedures had greater power for negatively correlated biospecimens than positively correlated biospecimens. These patterns were reversed when between-biospecimens differences were dissonant, meaning that power was greater for positively correlated biospecimens than for negatively correlated biospecimens. For the single biospecimen assessments, a Bonferroni adjustment was used to account for testing multiple biospecimens. 
Power when cases differ in only one biospecimen
In addition to simulating data with group differences in both biospecimens, we simulated data with group differences in only one biospecimen. In contrast to the findings when groups differed in both biospecimens, in this situation, the single biospecimen two-part tests had higher power than the T 2 g multi-biospecimen procedure at all levels of missing values and correlations ( Fig. 5 ; Supplemental Table S6 ). The single biospecimen two-part tests also had higher power than T g except when the biospecimens were strongly negatively correlated. As explained above, the variance of T g is smaller for negatively correlated biospecimens than positively correlated biospecimens resulting greater power for a given effect size. Because the T 2 g statistic combines information from both biospecimens, when cases differ from controls in only one of the biospecimens, the combined effect across the two biospecimens is reduced, resulting in lower power relative to the single-biospecimen tests. Although T 2 g was less powerful than the single biospecimen tests, in contrast to the findings when groups differed in both biospecimens, T 2 g was more powerful than T g except for strongly negatively correlated biospecimens.
Discussion
We investigated combining two-part statistics across biospecimens for identifying differentially regulated compounds measured through MS. The value of our approach is that it retains and uses information from all samples/biospecimens even if there are large numbers of missing values. By combining the test statistics from all biospecimens, we leveraged the evidence available from all biospecimens which increased statistical power relative to single biospecimen procedures under some circumstances. Although we focused on MS studies, our general approach is applicable to any other 'omics data types, such as genomic data or Copy Number Variation (CNV) data, in which missing values and/or censored values are present and multiple samples are taken per subject. While we used a t-statistic for Z gm , alternative test statistics for comparing measures of central tendency (e.g. means or medians) can be substituted for Z gm to reflect the underlying datagenerating distribution.
An alternative approach to analyzing multi-biospecimen data is to use multivariate analysis of variance. This method cannot accommodate missing values and thus is limited to compounds detected in all samples or necessitates imputing missing values. We previously reported that several imputation methods substantially impact inferential results of MANOVAs particularly when large amounts of missing values were present (Taylor et al., 2016) . Therefore, methods accommodating missing values are desirable. In this content, our proposed method is a valuable addition in testing multiple biospecimens simultaneously with missing values.
We found both multi-biospecimen test statistics to identify more differentially regulated compounds than any individual singlebiospecimen test. Through analysis of biological datasets and simulations, we found the multi-biospecimen T g testing procedure to be more powerful than all single-biospecimen methods considered when compounds are differentially regulated in the same direction in multiple biospecimens. Under this condition, T 2 g also is generally more powerful than single-biospecimen methods. However, if compounds are differentially regulated in different directions, T g has low power, while the T 2 g yields the highest power. Thus, in general, the multi-biospecimen procedures are more powerful if compounds are differentially regulated in multiple biospecimens. If however, a compound is differentially regulated in only one of the biospecimens, single biospecimen methods can be more powerful.
In our biological data examples, most compounds had consonant differences within and between biospecimens and the multibiospecimen methods identified more significantly different compounds than any single biospecimen method. Although the two multi-biospecimen methods identified most of the same compounds, for all of the datasets, there were some compounds found to be significant with only one method. Compounds identified as significant by T g and not T 2 g typically had consonant differences with negative between-biospecimen correlations. The simulations showed T g to be more powerful in this setting. In contrast, compounds identified as significant with T 2 g and not T g had dissonant differences between and within biospecimens which was consistent with the simulation findings. All of the testing procedures evaluated here, both the multiand single-specimen methods, evaluated the differences in means between groups which could be sensitive to extreme values. Because means can be strongly affected by extreme values, investigators may need to employ methods to assess their influence on estimation.
The choice of test statistic T g or T 2 g depends on the objectives of the particular experiment. If, for example, the primary objective of an experiment is to identify promising biomarkers in blood, an investigator might only be interested in compounds that are differentially regulated in the same direction in both plasma and serum. In contrast, in studies looking at varied biospecimens such as tissue, serum and urine, compounds of interest could be differentially regulated in different directions and identifying compounds that are responding to disease or treatment irrespective of direction might be the focus. In general, T g is to be preferred when interest is in compounds differentially regulated in the same direction in all or most biospecimens. This statistic yielded the highest power in this situation and was less likely than other procedures to identify significant results when (i) compounds are differentially regulated in different directions in the biospecimens and (ii) compounds are differentially regulated in only one of the biospecimens except if the biospecimens are strongly negatively correlated (q -0.5). If interest is in compounds that differ in several biospecimens but the direction of the regulation is not important or compounds could be regulated in different directions in different biospecimens, then T 2 g is preferred. Finally, we found single-biospecimen procedures to be most effective for detecting compounds that differ in only one biospecimen. In this setting the multi-biospecimen test statistics were dampened by the biospecimen with small differences in means and proportions.
To determine significance of the multi-biospecimen test statistics, we used a multivariate permutation. A resampling-based null distribution was necessary because the null distributions of the two multibiospecimen test statistics are unknown, but this approach offered several additional advantages. First, permutation null distributions are useful for studies with small sample sizes where asymptotic assumptions are questionable. Second, the multivariate permutation procedure retains the between-biospecimen correlation structure. Finally, it retains the within-biospecimen correlation structure and estimates the joint distribution of the test statistics across all compounds which can yield more powerful multiple testing procedures (Ge et al., 2003) . However, with very small sample sizes, the permutation null distribution can be very discrete and p-values might not be very decisive.
In this investigation, we compared two groups-cases versus controls. The general approach of combining test statistics across biological biospecimens and using a multivariate permutation null distribution to determine significance can be extended to any number of experimental groups. For example, for each biospecimen a v 2 test statistic can be calculated to assess differences in the proportion of missing values across multiple groups. For mean differences across experimental groups, a v 2 test statistic could be calculated based on a likelihood ratio test. These statistics can then be summed within and between biospecimens to yield a multi-biospecimen testing procedure. In evaluating multiple groups, constructing a meaningful test statistic that is sensitive to the direction of the differences would require some care. Missing values are prevalent in mass spectrometry data. While multiple strategies for handling missing values are available for single-biospecimen analyses, extensions to multiple biospecimen studies are less developed. Our multi-biospecimen two-part statistics testing procedure incorporates missing values into the testing procedure thus avoiding dropping compounds with a large amount of missingness and/or imputing missing values.
